u2 os cells Search Results


94
Genecopoeia u 2 os cells
U 2 Os Cells, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u 2 os cells/product/Genecopoeia
Average 94 stars, based on 1 article reviews
u 2 os cells - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Elabscience Biotechnology u2os
Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in <t>U2OS,</t> 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA
U2os, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u2os/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
u2os - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology u2os cell lysate
Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in <t>U2OS,</t> 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA
U2os Cell Lysate, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u2os cell lysate/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
u2os cell lysate - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures u-2 os
Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in <t>U2OS,</t> 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA
U 2 Os, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
u-2 os - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MARINPHARM gmbh human bone cell line u-2-os
Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in <t>U2OS,</t> 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA
Human Bone Cell Line U 2 Os, supplied by MARINPHARM gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human bone cell line u-2-os/product/MARINPHARM gmbh
Average 90 stars, based on 1 article reviews
human bone cell line u-2-os - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Institut Curie u-2 os/centrin-green fluorescent protein (gfp) cells
CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient <t>transfection</t> with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.
U 2 Os/Centrin Green Fluorescent Protein (Gfp) Cells, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os/centrin-green fluorescent protein (gfp) cells/product/Institut Curie
Average 90 stars, based on 1 article reviews
u-2 os/centrin-green fluorescent protein (gfp) cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection u-2 os cells
CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient <t>transfection</t> with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.
U 2 Os Cells, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os cells/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
u-2 os cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioResource International Inc u-2 os cells
CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient <t>transfection</t> with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.
U 2 Os Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os cells/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
u-2 os cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cellumen Inc u-2 os cells
CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient <t>transfection</t> with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.
U 2 Os Cells, supplied by Cellumen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os cells/product/Cellumen Inc
Average 90 stars, based on 1 article reviews
u-2 os cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Labtek yap–halotag crispr knock-in u-2 os cells

Yap–Halotag Crispr Knock In U 2 Os Cells, supplied by Labtek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/yap–halotag crispr knock-in u-2 os cells/product/Labtek
Average 90 stars, based on 1 article reviews
yap–halotag crispr knock-in u-2 os cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Institut Curie u-2 os osteosarcoma cells line stably expressing a centrin-gpf-encoding construct

U 2 Os Osteosarcoma Cells Line Stably Expressing A Centrin Gpf Encoding Construct, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/u-2 os osteosarcoma cells line stably expressing a centrin-gpf-encoding construct/product/Institut Curie
Average 90 stars, based on 1 article reviews
u-2 os osteosarcoma cells line stably expressing a centrin-gpf-encoding construct - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Molecular Medicine LLC bone osteosarcoma cell line u2-os

Bone Osteosarcoma Cell Line U2 Os, supplied by Molecular Medicine LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bone osteosarcoma cell line u2-os/product/Molecular Medicine LLC
Average 90 stars, based on 1 article reviews
bone osteosarcoma cell line u2-os - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in U2OS, 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA

Journal: Bone Research

Article Title: Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma

doi: 10.1038/s41413-025-00453-w

Figure Lengend Snippet: Chemotherapeutic drugs induced SG assembly and triggered AEP to specifically cleave G3BP1 at N258/N309. a Representative immunofluorescences (IF) images of SG assembly in U2OS, 143B, U87-MG and A549 cells exposed to cisplatin (5 and 50 μmol/L) or vehicle for 6 h. Scale Bar = 10 μm. b Quantification of the counts of SGs per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c WB analysis of G3BP1 and AEP in U2OS and 143B with NC or AEP-knockdown (KD) exposed to different chemotherapeutic drugs for 6 h. The arrows point out the truncated fragments of G3BP1 cleaved by AEP. d In vitro cleavage experiment of AEP and G3BP1 (WT and point mutants) purified recombinant proteins. Data are expressed as mean ± SD. *** P < 0.001, **** P < 0. 0001. Comparisons were conducted using one-way ANOVA

Article Snippet: Stable cell lines of U2OS, 143B, and U87-MG were seeded in 96-well cell culture plates and treated with cisplatin (50 μmol/L) or appropriate vehicle solution for 6 h. OCR Fluorometric Assay Kit (Cat# E-BC-F068, Elabscience, Wuhan, China) was used according to manufacturer’s protocol.

Techniques: Knockdown, In Vitro, Purification, Recombinant

tG3BP1-Ns competitively bind to full-length G3BP1 and negatively modulate SG. a Representative images of SGs in U2OS cells with or without AEP-KD exposed to cisplatin (50 μmol/L), doxorubicin (50 μmol/L) for 6 h. Scale bar = 10 μm. b Quantification of the SG counts per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c Representative images of G3BP1-FL colocalized with tG3BP1-Ns or tG3BP1-Cs in Hela cells. Scale bar = 5 μm. d Co-IP and WB assays of mCherry-tagged tG3BP1-Ns or Cs cotransfected with flag-tagged full-length G3BP1 in HEK293T. e Representative images of SGs in tG3BP1-Ns overexpressed U2OS cells exposed to cisplatin (5 μmol/L), doxorubicin (5 μmol/L) for 6 h. Scale bar = 10 μm. f Quantification of SG counts per cell ( n = 50) and SG + cell ratio ( n = 6) of ( e ). Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.000 1. ns no significance. One-way ANOVA

Journal: Bone Research

Article Title: Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma

doi: 10.1038/s41413-025-00453-w

Figure Lengend Snippet: tG3BP1-Ns competitively bind to full-length G3BP1 and negatively modulate SG. a Representative images of SGs in U2OS cells with or without AEP-KD exposed to cisplatin (50 μmol/L), doxorubicin (50 μmol/L) for 6 h. Scale bar = 10 μm. b Quantification of the SG counts per cell ( n = 50) and SG + cell ratio ( n = 6) in cells of ( a ). c Representative images of G3BP1-FL colocalized with tG3BP1-Ns or tG3BP1-Cs in Hela cells. Scale bar = 5 μm. d Co-IP and WB assays of mCherry-tagged tG3BP1-Ns or Cs cotransfected with flag-tagged full-length G3BP1 in HEK293T. e Representative images of SGs in tG3BP1-Ns overexpressed U2OS cells exposed to cisplatin (5 μmol/L), doxorubicin (5 μmol/L) for 6 h. Scale bar = 10 μm. f Quantification of SG counts per cell ( n = 50) and SG + cell ratio ( n = 6) of ( e ). Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.000 1. ns no significance. One-way ANOVA

Article Snippet: Stable cell lines of U2OS, 143B, and U87-MG were seeded in 96-well cell culture plates and treated with cisplatin (50 μmol/L) or appropriate vehicle solution for 6 h. OCR Fluorometric Assay Kit (Cat# E-BC-F068, Elabscience, Wuhan, China) was used according to manufacturer’s protocol.

Techniques: Co-Immunoprecipitation Assay

tG3BP1-Cs translocate into the nucleolus and sequester mRNAs of ribosomal proteins in the nucleolus to inhibit cellular translation. a Representative images of the sub-nucleolar localization of tG3BP1-Cs and sub-nucleolar markers in Hela cells. Scale bar = 5 μm. b Representative images of FISH and IF assays present the nucleolar colocalization of tG3BP1-Cs with FAM-conjugated probes of ribosomal mRNAs, RPS4X, RPL11, and RP27A. c SUnSET experiments analyzed the protein synthesis in U2OS, 143B, and U87-MG cells treated with cisplatin (50 μmol/L) or vehicle for 6 h. d Quantification of protein synthesis of the aforementioned cell lines exposed to cisplatin (50 μmol/L) or vehicle for 6 h were detected with the Click-iT HPG system ( n = 3). Data are expressed as mean ± SD. ** P < 0.01, **** P < 0.000 1. ns no significance. One-way ANOVA

Journal: Bone Research

Article Title: Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma

doi: 10.1038/s41413-025-00453-w

Figure Lengend Snippet: tG3BP1-Cs translocate into the nucleolus and sequester mRNAs of ribosomal proteins in the nucleolus to inhibit cellular translation. a Representative images of the sub-nucleolar localization of tG3BP1-Cs and sub-nucleolar markers in Hela cells. Scale bar = 5 μm. b Representative images of FISH and IF assays present the nucleolar colocalization of tG3BP1-Cs with FAM-conjugated probes of ribosomal mRNAs, RPS4X, RPL11, and RP27A. c SUnSET experiments analyzed the protein synthesis in U2OS, 143B, and U87-MG cells treated with cisplatin (50 μmol/L) or vehicle for 6 h. d Quantification of protein synthesis of the aforementioned cell lines exposed to cisplatin (50 μmol/L) or vehicle for 6 h were detected with the Click-iT HPG system ( n = 3). Data are expressed as mean ± SD. ** P < 0.01, **** P < 0.000 1. ns no significance. One-way ANOVA

Article Snippet: Stable cell lines of U2OS, 143B, and U87-MG were seeded in 96-well cell culture plates and treated with cisplatin (50 μmol/L) or appropriate vehicle solution for 6 h. OCR Fluorometric Assay Kit (Cat# E-BC-F068, Elabscience, Wuhan, China) was used according to manufacturer’s protocol.

Techniques:

tG3BP1-Cs bind to mitochondrial mRNA targets and suppress their translation to alleviate mitochondrial stress. a Representative images of the colocalization of tG3BP1-Cs with the mitochondrial marker TOMM20 in Hela cells. Scale bar = 10 μm. b RNP-IP analysis of the mRNA target encoding ribosomal proteins and oxidative phosphorylation binding to tG3BP1-Cs ( n = 3) in tG3BP1-Cs overexpressed U2OS cells. c Ribosome profiling-qPCR analysis demonstrated that tG3BP1 overexpression in U2OS cells significantly downregulates mitochondrial genes translation. d WB analysis of mitochondrial genes expression in cell lines exposed to cisplatin (50 μmol/L) or vehicle for 6 h. e Cisplatin-induced mitochondrial damage was detected by JC-1 probe staining in cells of ( d ). Data are expressed as mean ± SD. *** P < 0.001, **** P < 0.000 1. One-way ANOVA

Journal: Bone Research

Article Title: Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma

doi: 10.1038/s41413-025-00453-w

Figure Lengend Snippet: tG3BP1-Cs bind to mitochondrial mRNA targets and suppress their translation to alleviate mitochondrial stress. a Representative images of the colocalization of tG3BP1-Cs with the mitochondrial marker TOMM20 in Hela cells. Scale bar = 10 μm. b RNP-IP analysis of the mRNA target encoding ribosomal proteins and oxidative phosphorylation binding to tG3BP1-Cs ( n = 3) in tG3BP1-Cs overexpressed U2OS cells. c Ribosome profiling-qPCR analysis demonstrated that tG3BP1 overexpression in U2OS cells significantly downregulates mitochondrial genes translation. d WB analysis of mitochondrial genes expression in cell lines exposed to cisplatin (50 μmol/L) or vehicle for 6 h. e Cisplatin-induced mitochondrial damage was detected by JC-1 probe staining in cells of ( d ). Data are expressed as mean ± SD. *** P < 0.001, **** P < 0.000 1. One-way ANOVA

Article Snippet: Stable cell lines of U2OS, 143B, and U87-MG were seeded in 96-well cell culture plates and treated with cisplatin (50 μmol/L) or appropriate vehicle solution for 6 h. OCR Fluorometric Assay Kit (Cat# E-BC-F068, Elabscience, Wuhan, China) was used according to manufacturer’s protocol.

Techniques: Marker, Phospho-proteomics, Binding Assay, Over Expression, Expressing, Staining

CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient transfection with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.

Journal: Neoplasia (New York, N.Y.)

Article Title: CAND1 Promotes PLK4-Mediated Centriole Overduplication and Is Frequently Disrupted in Prostate Cancer 1

doi:

Figure Lengend Snippet: CAND1 stabilizes PLK4 and synergizes with PLK4 to induce centriole overduplication. (A) Immunoblot analysis of U-2 OS/centrin-GFP cells for CUL1 and CUL1 deletion mutants. Immunoblot for actin is shown for protein loading. (B) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication (more than four per cell and at least one maternal centriole with more than one 1 daughter) following transient transfection with empty vector (control), CUL1, or CUL1 mutants. Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .05, Student's t test for independent samples, two-tailed). (C) Cell cycle distribution after transient transfection of U-2 OS/centrin-GFP cells as assessed by flow cytometry. (D, E) Immunoblot analysis of U-2 OS/centrin-GFP cells for PLK4 (anti-myc) or CUL1 mutants (anti-HA) 48 hours after transfection with PLK4-myc, CUL1-ΔN53-HA or CUL1-CΔ22-HA transfection (0-hour CHX), or after 6-hour CHX block. GAPDH is shown to demonstrate protein loading. (F) Fluorescence microscopic analysis of U-2 OS/centrin-GFP cells following transfection with either empty vector (control) or PLK4. Note the concurrent formation of multiple daughter centrioles at single maternal centrioles (“centriole flower”), which is highly characteristic for PLK4 overexpression (right panel). Scale bar, 5 µm. (G) Quantification of the percentage of U-2 OS/centrin-GFP cells with centriole overduplication after transfection with PLK4 alone (open bars, µg of PLK4 plasmid DNA transfected as indicated) or in combination with CAND1 (black bars). Mean and standard errors of three independent experiments are shown. Asterisks indicate statistically significant differences (P < .005, Student's t test for independent samples, two-tailed). (H) Immunoblot analysis of U-2 OS/centrin-GFP cells for CAND1 and PLK4 (anti-myc tag), CUL1 or actin after transient transfection of cells with empty myc tag vector (control), CAND1-myc, and/or PLK4-myc and treatment of cells with CHX (60 µg/ml) for the indicated time intervals. Note the increased protein expression of PLK4 in cells cotransfected with CAND1 after 6-hour CHX in comparison to the decreased protein expression when PLK4 is expressed individually.

Article Snippet: Cell Culture and Transfections U-2 OS/centrin-green fluorescent protein (GFP) cells (centrin-GFP construct kindly provided by Michel Bornens, Institut Curie, Paris, France) [ 22 ] were cultured and transiently transfected as previously described [ 12 ].

Techniques: Western Blot, Transfection, Plasmid Preparation, Control, Two Tailed Test, Flow Cytometry, Blocking Assay, Fluorescence, Over Expression, Expressing, Comparison

Journal: iScience

Article Title: YAP condensates are highly organized hubs

doi: 10.1016/j.isci.2024.109927

Figure Lengend Snippet:

Article Snippet: The YAP–HaloTag CRISPR knock-in U-2 OS cells were plated into eight-well LabTek chambered coverglass dishes (life technologies, 155409PK) for drug treatment and imaging the following day.

Techniques: Virus, Recombinant, Modification, Protease Inhibitor, Transfection, Reverse Transcription, SYBR Green Assay, Hybridization, Single Particle, CRISPR, Knock-In, Negative Control, Plasmid Preparation, Software